Presentation TCT 2024 TCT 428: Efficacy and Safety of a Novel Ultra-Thin Arsenic Trioxide-Tacrolimus Eluting Stent in Porcine Coronary Artery Presenter: Han Chen October 29, 2024
Presentation TCT 2024 TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial Presenter: han zhang October 29, 2024
Presentation TCT 2024 TCT 781: Trends of Acute Myocardial Infarction Related Deaths in US Patients From 1999 to 2020 Presenter: Hanzala Farooqi October 29, 2024
Presentation TCT 2024 TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 783: Regional and State-Level Trends in Heart Attack Mortality in the United States: An Analysis Using the CDC's Interactive Atlas Presenter: Surik Sedrakyan October 29, 2024
Presentation TCT 2024 TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials Presenter: Michael Sabina October 29, 2024
Presentation TCT 2024 TCT 279: Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Patients Undergoing Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock Presenter: Atsuyuki Watanabe October 29, 2024
Presentation TCT 2024 TCT 785: Post-Procedural Patient-Reported Outcomes and Quality of Life Is Worse in Women Than Men Despite Similar Post-PCI VFFR Values Presenter: Karol Sadowski October 29, 2024
Presentation TCT 2024 TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades Presenter: Ahmed Abdulelah October 29, 2024
Presentation TCT 2024 TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial Presenter: Jennifer Tremmel October 29, 2024
Presentation TCT 2024 TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis Presenter: Leonardo Sinnott Silva October 29, 2024
Presentation TCT 2024 My Personal Guide to Management of Patients Returning Due to Target Vessel Failure Presenter: Stuart Watkins October 29, 2024
Presentation TCT 2024 TCT 1182: Chronic Immunosuppression May Increase the Risk of Coronary Artery Perforation in Patients Undergoing CTO-PCI Presenter: Mina Bhatnagar October 29, 2024
Presentation TCT 2024 TCT 1201: When the Left Main Is a Side Branch Presenter: Zvonimir Ostojic October 29, 2024
Presentation TCT 2024 TCT 1115: Sever LM Stenosis and Aortic Stenosis Presenter: Abdulaziz Algethami October 29, 2024
Presentation TCT 2024 TCT 1595: Heavily Calcified Bifurcating Chronic Total Occlusions Presenter: Louai Razzouk October 29, 2024
Presentation TCT 2024 TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents? Presenter: Han Chen October 29, 2024
Presentation TCT 2024 TCT 1238: Orthotopic Left Main Chimney Stenting to Prevent Stent Compression Following Transcatheter Aortic Valve Replacement in a Patient With a Narrow Aortic Root Presenter: Ruxandra Sava October 29, 2024
Presentation TCT 2024 Magenta Elevate: Breaking the Flow/Fr Size Ceiling of Mechanical Circulatory Support Presenter: Perwaiz Meraj October 29, 2024